Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | REPL | XPEL |
|---|---|---|
| Price | $13.15 | $44.99 |
| Change today | ▲ 0.61% | ▲ 0.04% |
| Market cap | $1.24B | $1.24B |
| Return, 3 months | +14.2% | -10.1% |
| Return, year to date | +35.3% | -9.9% |
| Return, 1 year | +181.0% | +34.1% |
| P/E (TTM) | -4.2 | 22.7 |
| P/B | 11.7 | 4.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +45.8% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 48 | 45 |
| 30-day volatility | 47.4% | 28.3% |
| Max drawdown, 1 year | -84.2% | -31.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
